Add to ORKGpharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malari
Mefloquine has an established place in the treatment of chloroquine-resistant falciparum malaria. To...
The pharmacokinetic properties of mefloquine hydrochloride (15 mg base kg -1) were studied in 12 Kar...
Population pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-me...
OBJECTIVE: To construct a population pharmacokinetic model for mefloquine in the treatment of falcip...
OBJECTIVE: To construct a population pharmacokinetic model for mefloquine in the treatment of falcip...
Objective\ud \ud The purpose of this study was to determine the population pharmacokinetics of meflo...
Objective The purpose of this study was to determine the population pharmacokinetics of mefloquin...
Background Low mefloquine exposure has been shown to contribute to treatment failure in patients wit...
Objective: The purpose of this study was to determine the population pharmacokinetics of mefloquine ...
Background Low mefloquine exposure has been shown to contribute to treatment failure in patients wit...
Background The determination of dosing regimens for the treatment of malaria is largely empirical an...
Background Low mefloquine exposure has been shown to contribute to treatment failure in patients wit...
Abstract Background Low mefloquine exposure has been shown to contribute to treatment failure in pat...
Mefloquine-sulphadoxine-pyrimethamine (MSP) in combination has proved effective against multiple-dru...
To investigate the population pharmacokinetics of the antimalarial halofantrine (HF) in healthy volu...
Mefloquine has an established place in the treatment of chloroquine-resistant falciparum malaria. To...
The pharmacokinetic properties of mefloquine hydrochloride (15 mg base kg -1) were studied in 12 Kar...
Population pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-me...
OBJECTIVE: To construct a population pharmacokinetic model for mefloquine in the treatment of falcip...
OBJECTIVE: To construct a population pharmacokinetic model for mefloquine in the treatment of falcip...
Objective\ud \ud The purpose of this study was to determine the population pharmacokinetics of meflo...
Objective The purpose of this study was to determine the population pharmacokinetics of mefloquin...
Background Low mefloquine exposure has been shown to contribute to treatment failure in patients wit...
Objective: The purpose of this study was to determine the population pharmacokinetics of mefloquine ...
Background Low mefloquine exposure has been shown to contribute to treatment failure in patients wit...
Background The determination of dosing regimens for the treatment of malaria is largely empirical an...
Background Low mefloquine exposure has been shown to contribute to treatment failure in patients wit...
Abstract Background Low mefloquine exposure has been shown to contribute to treatment failure in pat...
Mefloquine-sulphadoxine-pyrimethamine (MSP) in combination has proved effective against multiple-dru...
To investigate the population pharmacokinetics of the antimalarial halofantrine (HF) in healthy volu...
Mefloquine has an established place in the treatment of chloroquine-resistant falciparum malaria. To...
The pharmacokinetic properties of mefloquine hydrochloride (15 mg base kg -1) were studied in 12 Kar...
Population pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-me...